Letters, Testimony & Comments

May 2010 National Security Strategy from the White House

NIST clarifies that device development is not a focus of 2010 TIP competition.

The National Vaccine Program was established in 1986 to achieve optimal prevention of infectious diseases through immunization and optimal prevention of adverse reactions to vaccines.

The environmental challenges of weed resistance are the same for biotech crops and conventional crops if farmers do not use herbicides as directed. Learn more about stewardship practices that help farmers better control weeds and how biotechnology…

This Report contains NVAC recommendations based on the Working Group’s findings and conclusions, and includes recommendations developed by the NVAC Adolescent Working Group. It takes into account public comments and extensive stakeholder input…

White House National Security Council - November 2009 National Strategy for Countering Biological Threats

Implementation of CAN will help NIH-funded researchers bridge the precarious gap between basic research and the eventual development of new cures and treatments for many of the diseases we face today.

BIO commends the SEC on its pilot circuit breaker proposal and urges the use of biotech companies in such proposal

The letter, signed by approximately 85 patient groups, requests appropriation for CAN in FY2011

BIO advocated for a provision in financial services reform that would ease regulatory burdens for small public biotechnology companies.